India’s Production-Linked Scheme Will Enhance Domestic Bulk Drug Manufacturing Capabilities

Key View

• India’s production-linked incentive scheme will reduce imports by promoting domestic manufacturing of pharmaceuticals.
• The country will remain keen to secure its drugs market from external shocks, lessen import dependencies, and continue support for the domestic production capabilities in APIs.
• Reducing India’s dependence on Mainland China will not be easy to achieve.